Bicara Therapeutics
Biotechnology • Boston, MA
About Bicara Therapeutics
Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibodies for solid tumors. Its lead candidate, ficerafusp alfa (BCA101), is an EGFR-targeting antibody fused to a TGF-β trap. It is being studied in head and neck squamous cell carcinoma and other cancers. Its mission is to improve outcomes for patients with difficult-to-treat cancers.
Company Information
Open Positions
Manager, GxP Document Control and Quality Systems
Biotechnology
Boston, MA · Hybrid
Full-Time